Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared on LinkedIn:
“I am pleased to share that I will be speaking at the Florida Society of Clinical Oncology’s 2026 Clinical Oncology Series: Malignant Hematology, taking place on August 29, 2026, at the Renaissance Tampa International Plaza Hotel.
I will present:
Precision in Myeloid Malignancies: Are We There Yet?
The program will bring together expert faculty for practical, interactive discussions on:
- Precision approaches in AML and MDS
- Treatment optimization and transplant debates in multiple myeloma
- Evolving standards in follicular lymphoma, DLBCL, and CLL
- Key updates from the summer oncology meetings
- Emerging treatment approaches in myeloproliferative neoplasms
The meeting offers 6.25 CE/CME credits for physicians, nurses, pharmacists, and physician associates. FLASCO members attend free.
Registration deadline: August 15, 2026
Hotel room-block deadline: August 7, 2026
I hope you will join us in Tampa for an engaging and clinically relevant educational program. I look forward to seeing many colleagues there.”
Other articles about precision oncology on OncoDaily.